Skip to main content

Study

Natural Supplement Offers Symptom Relief for Enlarged Prostate

A study found that a supplement from saw palmetto, selenium, and lycopene helps reduce urinary symptoms in older men, without affecting sexual function.

Prostate HealthSupplementsMen's Health
Study Credibility: Low4.7/10Early findingsNot enough evidence yetTalk with your clinician
PublishedJan 2025DesignRCTLast reviewedJun 2026
Email this

Summary

In plain language

A recent study explored how a natural supplement, combining Serenoa repens (saw palmetto), selenium, and lycopene, affects symptoms of an enlarged prostate in older men. The study showed this supplement can help reduce urinary symptoms similar to the drug Dutasteride, but without the side effects related to sexual function often seen with medications. Conducted over a year with men aged 55 to 80, the research highlighted that while both treatments improved urinary symptoms, the natural supplement did not diminish sexual health. This is encouraging news for seniors looking for effective prostate symptom management without compromising quality of life.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

The study involved 269 men aged 55 to 80, comparing the effects of a natural supplement (Serenoa repens, selenium, and lycopene) to the medication Dutasteride for prostate symptoms.

  • The research found both treatments improved urinary symptoms, but the supplement did not affect sexual function, unlike Dutasteride.

  • While Dutasteride reduced prostate size more significantly, the supplement offered similar symptom relief without sexual side effects.

  • Participants should know that while effective, the supplement may not reduce prostate size as much as the medication.

Talk with your healthcare provider to see if this supplement might be a suitable option for managing prostate symptoms.

Research Quality Score

Scored June 8, 2026 using rubric v9_2026-04-08.

Assessment

The study is a prospective non-randomized case-control design, which limits its evidence level due to lack of randomization. Bias control is limited by the non-randomized design and shared decision-making for treatment assignment. Statistical methods are appropriate but lack comprehensive reporting of power and effect sizes. Transparency is partial, with methods described but no protocol registration. Conflict of interest disclosure is present, but potential industry ties are a concern. The study is highly relevant to seniors, focusing on older men with BPH. Published in a reputable journal, but not top-tier.

Category Breakdown

CategoryScoreRating
Study design5.0/10
Bias control3.3/10
Statistical methods5.0/10
Reporting completeness5.0/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study's non-randomized design and potential conflicts of interest are significant limitations. Further replication and validation are needed to strengthen findings.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.